Risk-weighted apoB: a novel summary metric outperforming traditional lipid biomarkers in predicting coronary heart disease
RW-apoB represents not only particle number but also accounts for the higher atherogenicity of TRL and Lp(a). It offers clinically meaningful improvements in CHD risk stratification.
Authors
- T Fall
- Anders Gummesson (ORCID: https://orcid.org/0000-0003-0024-960X)
- Martin Adiels (ORCID: https://orcid.org/0000-0002-3667-589X)
- Ljubica Matic (ORCID: https://orcid.org/0000-0002-7294-9667)
- B. Rehman Michaela
- Elias Björnson (ORCID: https://orcid.org/0000-0002-0003-6463)
- David Erlinge
- Carl Johan Östgren
- Chris J. Packard
- Jakub Morze
- Jan Borén
- Göran Bergström
- Stefan Söderberg
Institutions
- Linköping University (SE)
- Uppsala University (SE)
- Lund University (SE)
- Science for Life Laboratory (SE)
- Sahlgrenska University Hospital (SE)
- Karolinska Institutet (SE)
- Region Västra Götaland (SE)
- Communauté urbaine de Lyon (FR)
- Chalmers University of Technology (SE)
- University of Glasgow (GB)
- University of Gothenburg (SE)
- Umeå University (SE)
Publication Details
- Journal
- European Heart Journal
- Published
- 2026-01-04
- DOI
- https://doi.org/10.1093/eurheartj/ehaf1124
- Citations
- 1
- Primary Topic
- Adipokines, Inflammation, and Metabolic Diseases
- Type
- article
- Field-Weighted Citation Impact
- 31.52